Carregant...
尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究
OBJECTIVE: To compare the cytogenetic and molecular responses, outcomes and severe hematologic toxicity of nilotinib and imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase（CML-CP）. METHODS: Newly diagnosed CML-CP patients were consecutively recru...
Guardat en:
| Publicat a: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial office of Chinese Journal of Hematology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342677/ https://ncbi.nlm.nih.gov/pubmed/32023729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|